About Transcenta Therapeutics Transcenta (HKEX: 06628) is a global clinical stage biopharmaceutical company with fully integrated capabilities in antibody-based biotherapeutics discovery, research, ...
Digital GMP expectations are increasing, driven by Annex 11 and Annex 22, necessitating robust lifecycle management, data ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback